{"id":{"repo_id":"clemson","oai_identifier":"oai:open.clemson.edu:all_theses-5430"},"canonical_url":"https://search.ndltd.org/etd/clemson/oai:open.clemson.edu:all_theses-5430","repository":{"repo_id":"clemson","name":"Clemson University","base_url":"https://open.clemson.edu/do/oai/"},"display":{"title":"A Drosophila Model of Mucopolysacchridosis IIIA","abstract":"Mucopolysaccharidosis IIIA (MPS IIIA) is a rare lysosomal storage disorder that arises from inability to break down heparan sulfate (HS) because of mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene. We used a deletion mutant of the Drosophila melanogaster Sgsh gene along with three point mutations analogous to mutations observed in patients (S64W, L89P, S301P) to show an increase in the average percent of area with lysosomal puncta in the fly brains of our mutants using Lysotracker. RNA sequencing of brains of mutant and control flies showed 441 (Knockout), 337 (S64W), 155 (L89P), and 96 (S301P) differentially expressed genes, including N-acetyl-alpha-glycosaminidase (Naglu) and N-acetylglucosamine 6-Sulfatase (GNS), which are both downstream from Sgsh in the HS catabolic pathway. Disruption of Sgsh expression impacts multiple interrelated biological processes, including developmental pathways, transcriptional regulation, RNA processing and nuclear transport, ribosome biogenesis, protein folding and proteolysis, metabolic pathways, and neurodevelopment. These observations indicate that D. melanogaster can serve as a model for MPS IIIA and lay the foundation for future comparative genomics approaches to assess the impact of background modifiers on variation in disease severity and penetrance.","abstract_html":"Mucopolysaccharidosis IIIA (MPS IIIA) is a rare lysosomal storage disorder that arises from inability to break down heparan sulfate (HS) because of mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene. We used a deletion mutant of the Drosophila melanogaster Sgsh gene along with three point mutations analogous to mutations observed in patients (S64W, L89P, S301P) to show an increase in the average percent of area with lysosomal puncta in the fly brains of our mutants using Lysotracker. RNA sequencing of brains of mutant and control flies showed 441 (Knockout), 337 (S64W), 155 (L89P), and 96 (S301P) differentially expressed genes, including N-acetyl-alpha-glycosaminidase (Naglu) and N-acetylglucosamine 6-Sulfatase (GNS), which are both downstream from Sgsh in the HS catabolic pathway. Disruption of Sgsh expression impacts multiple interrelated biological processes, including developmental pathways, transcriptional regulation, RNA processing and nuclear transport, ribosome biogenesis, protein folding and proteolysis, metabolic pathways, and neurodevelopment. These observations indicate that D. melanogaster can serve as a model for MPS IIIA and lay the foundation for future comparative genomics approaches to assess the impact of background modifiers on variation in disease severity and penetrance.","abstract_has_math":false,"creators":["Bishop, Rebecca"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Genetics and Biochemistry","degree_department":null,"school":null,"contributors":["Dr. Robert Anholt","Dr. Trudy Mackay","Dr. Lela Lackey","Dr. Richard Steet"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:33:12Z","subjects":["Rare Disease","Lysosomal Storage Disorder","Sanfilippo Syndrome","Mucopolysaccharidosis IIIA","Genetics","Genetics and Genomics","Life Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://open.clemson.edu/all_theses/4433","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://open.clemson.edu/all_theses/4433","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.clemson.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Aopen.clemson.edu%3Aall_theses-5430","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Robert Anholt","Dr. Trudy Mackay","Dr. Lela Lackey","Dr. Richard Steet"]},{"key":"dc:creator","label":"Author","values":["Bishop, Rebecca"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-11-12T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-12-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Genetics and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Rare Disease","Lysosomal Storage Disorder","Sanfilippo Syndrome","Mucopolysaccharidosis IIIA","Genetics","Genetics and Genomics","Life Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://open.clemson.edu/all_theses/4433"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Mucopolysaccharidosis IIIA (MPS IIIA) is a rare lysosomal storage disorder that arises from inability to break down heparan sulfate (HS) because of mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene. We used a deletion mutant of the Drosophila melanogaster Sgsh gene along with three point mutations analogous to mutations observed in patients (S64W, L89P, S301P) to show an increase in the average percent of area with lysosomal puncta in the fly brains of our mutants using Lysotracker. RNA sequencing of brains of mutant and control flies showed 441 (Knockout), 337 (S64W), 155 (L89P), and 96 (S301P) differentially expressed genes, including N-acetyl-alpha-glycosaminidase (Naglu) and N-acetylglucosamine 6-Sulfatase (GNS), which are both downstream from Sgsh in the HS catabolic pathway. Disruption of Sgsh expression impacts multiple interrelated biological processes, including developmental pathways, transcriptional regulation, RNA processing and nuclear transport, ribosome biogenesis, protein folding and proteolysis, metabolic pathways, and neurodevelopment. These observations indicate that D. melanogaster can serve as a model for MPS IIIA and lay the foundation for future comparative genomics approaches to assess the impact of background modifiers on variation in disease severity and penetrance."]},{"key":"dc:title","label":"Title","values":["A Drosophila Model of Mucopolysacchridosis IIIA"]}]}],"canonical_facts":{"dc:contributor":["Dr. Robert Anholt","Dr. Trudy Mackay","Dr. Lela Lackey","Dr. Richard Steet"],"dc:creator":["Bishop, Rebecca"],"dc:date.available":["2024-11-12T08:00:00Z"],"dc:date.created":["2024-12-01T08:00:00Z"],"dc:description.abstract":["Mucopolysaccharidosis IIIA (MPS IIIA) is a rare lysosomal storage disorder that arises from inability to break down heparan sulfate (HS) because of mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene. We used a deletion mutant of the Drosophila melanogaster Sgsh gene along with three point mutations analogous to mutations observed in patients (S64W, L89P, S301P) to show an increase in the average percent of area with lysosomal puncta in the fly brains of our mutants using Lysotracker. RNA sequencing of brains of mutant and control flies showed 441 (Knockout), 337 (S64W), 155 (L89P), and 96 (S301P) differentially expressed genes, including N-acetyl-alpha-glycosaminidase (Naglu) and N-acetylglucosamine 6-Sulfatase (GNS), which are both downstream from Sgsh in the HS catabolic pathway. Disruption of Sgsh expression impacts multiple interrelated biological processes, including developmental pathways, transcriptional regulation, RNA processing and nuclear transport, ribosome biogenesis, protein folding and proteolysis, metabolic pathways, and neurodevelopment. These observations indicate that D. melanogaster can serve as a model for MPS IIIA and lay the foundation for future comparative genomics approaches to assess the impact of background modifiers on variation in disease severity and penetrance."],"dc:identifier":["https://open.clemson.edu/all_theses/4433"],"dc:subject":["Rare Disease","Lysosomal Storage Disorder","Sanfilippo Syndrome","Mucopolysaccharidosis IIIA","Genetics","Genetics and Genomics","Life Sciences"],"dc:title":["A Drosophila Model of Mucopolysacchridosis IIIA"],"thesis:degree_discipline":["Genetics and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T07:33:12Z"}